Replies to post #586600 on NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Strangely enough, Linda Powers is doing enough in her own right — her own bear imitation, if you will — to keep the stock price low w/ regard to lack of BP interest in combo trials. I said before that at this stage in the approval process when it involves potential BP deals, everyone is lying.

See her quote from the ASM:

We have actually -- we actually walked away from a combo trial that we could have proceeded with before. The terms were quite unfavorable with us supposed to supply everything and receive very little. So we're not going to do that. So anyway, that's our perspective on combo trials. One other thing that wasn't in this question, but just to remind, and we said this in our JAMA Oncology publication also, it's in the discussion section, that we believe from everything that we have seen about the DCVax and how it operates, we believe DCVax can potentially be applicable to a wide range of solid tumors, possibly even virtually all the different types of solid tumors.

[667849378]

What Jefferies analyst comments are your referencing? Could you provide a link? Thanks.

[iclight]

Nobody is "keeping the price low" except the company not being worth the ask price. This company only traded 2.8 million yesterday because there were 2.8 million buyers who were willing to pay around $0.55.

The SP has dropped %50 since TLD because TLD was horrible and the trial is a failure by any metric except those of bagholders.